This is a sample report.
Get yours →
Sample StackDNA Report
Generated for: Example User • January 2026
Executive Summary
Analysis of 54 genetic markers across 10 categories reveals several actionable findings that inform your supplement protocol:
- Moderate MTHFR C677T heterozygous — reduced folate enzyme activity (~65%). Use methylfolate instead of folic acid.
- Moderate COMT Val158Met (Met/Met) — slow dopamine clearance. Start methylation support at low doses.
- Normal APOE ε3/ε3 — standard cardiovascular and Alzheimer’s risk profile.
- Flagged CYP1A2 slow metabolizer — caffeine sensitivity. Limit to 1 cup/day before noon.
Methylation Pathway
| Gene | SNP | Your Result | Impact |
|---|---|---|---|
| MTHFR | rs1801133 | AG | Moderate |
| MTHFR | rs1801131 | TT | Normal |
| MTR | rs1805087 | AA | Normal |
| MTRR | rs1801394 | AG | Moderate |
| COMT | rs4680 | AA | Moderate |
Your MTHFR variant reduces enzyme function by approximately 35%. Combined with your MTRR variant, methylation support with methylfolate (400–800 mcg) and methylcobalamin B12 is recommended.
Supplement Schedule Preview
Morning (with breakfast)
- Methylfolate 400 mcg
- Methylcobalamin B12 1000 mcg
- Vitamin D3 + K2 (5000 IU / 100 mcg)
- Omega-3 (EPA/DHA 1000 mg)
Evening (with dinner)
- CoQ10 Ubiquinol 200 mg
- Magnesium Glycinate 300 mg
- Taurine 1000 mg
Diet & Nutrition Guidance
Based on your BCMO1 and FUT2 variants, you may benefit from preformed vitamin A sources and adjusted B12 intake strategies...
Your full report continues here
More detailed sections including shopping list and personalized diet guidance
Get Your ReportReady for your personalized report?
Same depth. Tailored to your DNA.
Get Your Personalized Protocol — $59